The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oxycodone Drug Market Research Report 2025
Synopsis
Oxycodoneis an opioid medication. It comes in tablet shape or liquid formation. It is used for the treatment of moderate to severe pain.
The global Oxycodone Drug market was valued at US$ 2255 million in 2023 and is anticipated to reach US$ 3480.1 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oxycodone Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxycodone Drug.
Report Scope
The Oxycodone Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oxycodone Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxycodone Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Purdue Pharma L.P
Janssen Pharmaceuticals(Johnson & Johnson)
Hikma Pharmaceuticals USA
Pfizer
Sanofi-Aventis S.A.
Sun Pharmaceutical Industries Ltd.
Oxynorm
OxyContin
Endone
Proladone
Targin
Segment by Type
Pain Management
Anesthesia
Others
Segment by Application
Hospitals & Clinics
Ambulatory Surgical Centers (ASCs)
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oxycodone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oxycodone Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Oxycodoneis an opioid medication. It comes in tablet shape or liquid formation. It is used for the treatment of moderate to severe pain.
The global Oxycodone Drug market was valued at US$ 2255 million in 2023 and is anticipated to reach US$ 3480.1 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oxycodone Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxycodone Drug.
Report Scope
The Oxycodone Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oxycodone Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxycodone Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Purdue Pharma L.P
Janssen Pharmaceuticals(Johnson & Johnson)
Hikma Pharmaceuticals USA
Pfizer
Sanofi-Aventis S.A.
Sun Pharmaceutical Industries Ltd.
Oxynorm
OxyContin
Endone
Proladone
Targin
Segment by Type
Pain Management
Anesthesia
Others
Segment by Application
Hospitals & Clinics
Ambulatory Surgical Centers (ASCs)
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oxycodone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oxycodone Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oxycodone Drug Market Overview
1.1 Product Overview and Scope of Oxycodone Drug
1.2 Oxycodone Drug Segment by Type
1.2.1 Global Oxycodone Drug Market Value Comparison by Type (2024-2030)
1.2.2 Pain Management
1.2.3 Anesthesia
1.2.4 Others
1.3 Oxycodone Drug Segment by Application
1.3.1 Global Oxycodone Drug Market Value by Application: (2024-2030)
1.3.2 Hospitals & Clinics
1.3.3 Ambulatory Surgical Centers (ASCs)
1.4 Global Oxycodone Drug Market Size Estimates and Forecasts
1.4.1 Global Oxycodone Drug Revenue 2019-2030
1.4.2 Global Oxycodone Drug Sales 2019-2030
1.4.3 Global Oxycodone Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oxycodone Drug Market Competition by Manufacturers
2.1 Global Oxycodone Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oxycodone Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oxycodone Drug Average Price by Manufacturers (2019-2024)
2.4 Global Oxycodone Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oxycodone Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oxycodone Drug, Product Type & Application
2.7 Oxycodone Drug Market Competitive Situation and Trends
2.7.1 Oxycodone Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oxycodone Drug Players Market Share by Revenue
2.7.3 Global Oxycodone Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oxycodone Drug Retrospective Market Scenario by Region
3.1 Global Oxycodone Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oxycodone Drug Global Oxycodone Drug Sales by Region: 2019-2030
3.2.1 Global Oxycodone Drug Sales by Region: 2019-2024
3.2.2 Global Oxycodone Drug Sales by Region: 2025-2030
3.3 Global Oxycodone Drug Global Oxycodone Drug Revenue by Region: 2019-2030
3.3.1 Global Oxycodone Drug Revenue by Region: 2019-2024
3.3.2 Global Oxycodone Drug Revenue by Region: 2025-2030
3.4 North America Oxycodone Drug Market Facts & Figures by Country
3.4.1 North America Oxycodone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oxycodone Drug Sales by Country (2019-2030)
3.4.3 North America Oxycodone Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oxycodone Drug Market Facts & Figures by Country
3.5.1 Europe Oxycodone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oxycodone Drug Sales by Country (2019-2030)
3.5.3 Europe Oxycodone Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oxycodone Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Oxycodone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oxycodone Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Oxycodone Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Oxycodone Drug Market Facts & Figures by Country
3.7.1 Latin America Oxycodone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oxycodone Drug Sales by Country (2019-2030)
3.7.3 Latin America Oxycodone Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oxycodone Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Oxycodone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oxycodone Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oxycodone Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oxycodone Drug Sales by Type (2019-2030)
4.1.1 Global Oxycodone Drug Sales by Type (2019-2024)
4.1.2 Global Oxycodone Drug Sales by Type (2025-2030)
4.1.3 Global Oxycodone Drug Sales Market Share by Type (2019-2030)
4.2 Global Oxycodone Drug Revenue by Type (2019-2030)
4.2.1 Global Oxycodone Drug Revenue by Type (2019-2024)
4.2.2 Global Oxycodone Drug Revenue by Type (2025-2030)
4.2.3 Global Oxycodone Drug Revenue Market Share by Type (2019-2030)
4.3 Global Oxycodone Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oxycodone Drug Sales by Application (2019-2030)
5.1.1 Global Oxycodone Drug Sales by Application (2019-2024)
5.1.2 Global Oxycodone Drug Sales by Application (2025-2030)
5.1.3 Global Oxycodone Drug Sales Market Share by Application (2019-2030)
5.2 Global Oxycodone Drug Revenue by Application (2019-2030)
5.2.1 Global Oxycodone Drug Revenue by Application (2019-2024)
5.2.2 Global Oxycodone Drug Revenue by Application (2025-2030)
5.2.3 Global Oxycodone Drug Revenue Market Share by Application (2019-2030)
5.3 Global Oxycodone Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Purdue Pharma L.P
6.1.1 Purdue Pharma L.P Corporation Information
6.1.2 Purdue Pharma L.P Description and Business Overview
6.1.3 Purdue Pharma L.P Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Purdue Pharma L.P Oxycodone Drug Product Portfolio
6.1.5 Purdue Pharma L.P Recent Developments/Updates
6.2 Janssen Pharmaceuticals(Johnson & Johnson)
6.2.1 Janssen Pharmaceuticals(Johnson & Johnson) Corporation Information
6.2.2 Janssen Pharmaceuticals(Johnson & Johnson) Description and Business Overview
6.2.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio
6.2.5 Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments/Updates
6.3 Hikma Pharmaceuticals USA
6.3.1 Hikma Pharmaceuticals USA Corporation Information
6.3.2 Hikma Pharmaceuticals USA Description and Business Overview
6.3.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio
6.3.5 Hikma Pharmaceuticals USA Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Oxycodone Drug Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Sanofi-Aventis S.A.
6.5.1 Sanofi-Aventis S.A. Corporation Information
6.5.2 Sanofi-Aventis S.A. Description and Business Overview
6.5.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio
6.5.5 Sanofi-Aventis S.A. Recent Developments/Updates
6.6 Sun Pharmaceutical Industries Ltd.
6.6.1 Sun Pharmaceutical Industries Ltd. Corporation Information
6.6.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio
6.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
6.7 Oxynorm
6.6.1 Oxynorm Corporation Information
6.6.2 Oxynorm Description and Business Overview
6.6.3 Oxynorm Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Oxynorm Oxycodone Drug Product Portfolio
6.7.5 Oxynorm Recent Developments/Updates
6.8 OxyContin
6.8.1 OxyContin Corporation Information
6.8.2 OxyContin Description and Business Overview
6.8.3 OxyContin Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 OxyContin Oxycodone Drug Product Portfolio
6.8.5 OxyContin Recent Developments/Updates
6.9 Endone
6.9.1 Endone Corporation Information
6.9.2 Endone Description and Business Overview
6.9.3 Endone Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Endone Oxycodone Drug Product Portfolio
6.9.5 Endone Recent Developments/Updates
6.10 Proladone
6.10.1 Proladone Corporation Information
6.10.2 Proladone Description and Business Overview
6.10.3 Proladone Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Proladone Oxycodone Drug Product Portfolio
6.10.5 Proladone Recent Developments/Updates
6.11 Targin
6.11.1 Targin Corporation Information
6.11.2 Targin Oxycodone Drug Description and Business Overview
6.11.3 Targin Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Targin Oxycodone Drug Product Portfolio
6.11.5 Targin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oxycodone Drug Industry Chain Analysis
7.2 Oxycodone Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oxycodone Drug Production Mode & Process
7.4 Oxycodone Drug Sales and Marketing
7.4.1 Oxycodone Drug Sales Channels
7.4.2 Oxycodone Drug Distributors
7.5 Oxycodone Drug Customers
8 Oxycodone Drug Market Dynamics
8.1 Oxycodone Drug Industry Trends
8.2 Oxycodone Drug Market Drivers
8.3 Oxycodone Drug Market Challenges
8.4 Oxycodone Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Oxycodone Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oxycodone Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Oxycodone Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oxycodone Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Oxycodone Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oxycodone Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oxycodone Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oxycodone Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oxycodone Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oxycodone Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oxycodone Drug, Product Type & Application
Table 12. Global Key Manufacturers of Oxycodone Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oxycodone Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxycodone Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oxycodone Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oxycodone Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Oxycodone Drug Sales Market Share by Region (2019-2024)
Table 19. Global Oxycodone Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Oxycodone Drug Sales Market Share by Region (2025-2030)
Table 21. Global Oxycodone Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oxycodone Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Oxycodone Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oxycodone Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Oxycodone Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oxycodone Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Oxycodone Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Oxycodone Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oxycodone Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oxycodone Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oxycodone Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Oxycodone Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Oxycodone Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oxycodone Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oxycodone Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oxycodone Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Oxycodone Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Oxycodone Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oxycodone Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oxycodone Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oxycodone Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Oxycodone Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Oxycodone Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oxycodone Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oxycodone Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Oxycodone Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Oxycodone Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Oxycodone Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Oxycodone Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oxycodone Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Oxycodone Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Oxycodone Drug Sales Market Share by Type (2019-2024)
Table 53. Global Oxycodone Drug Sales Market Share by Type (2025-2030)
Table 54. Global Oxycodone Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oxycodone Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oxycodone Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Oxycodone Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Oxycodone Drug Price (USD/Unit) by Type (2019-2024)
Table 59. Global Oxycodone Drug Price (USD/Unit) by Type (2025-2030)
Table 60. Global Oxycodone Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Oxycodone Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Oxycodone Drug Sales Market Share by Application (2019-2024)
Table 63. Global Oxycodone Drug Sales Market Share by Application (2025-2030)
Table 64. Global Oxycodone Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oxycodone Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oxycodone Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Oxycodone Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Oxycodone Drug Price (USD/Unit) by Application (2019-2024)
Table 69. Global Oxycodone Drug Price (USD/Unit) by Application (2025-2030)
Table 70. Purdue Pharma L.P Corporation Information
Table 71. Purdue Pharma L.P Description and Business Overview
Table 72. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Purdue Pharma L.P Oxycodone Drug Product
Table 74. Purdue Pharma L.P Recent Developments/Updates
Table 75. Janssen Pharmaceuticals(Johnson & Johnson) Corporation Information
Table 76. Janssen Pharmaceuticals(Johnson & Johnson) Description and Business Overview
Table 77. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product
Table 79. Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments/Updates
Table 80. Hikma Pharmaceuticals USA Corporation Information
Table 81. Hikma Pharmaceuticals USA Description and Business Overview
Table 82. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Hikma Pharmaceuticals USA Oxycodone Drug Product
Table 84. Hikma Pharmaceuticals USA Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer Oxycodone Drug Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Sanofi-Aventis S.A. Corporation Information
Table 91. Sanofi-Aventis S.A. Description and Business Overview
Table 92. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi-Aventis S.A. Oxycodone Drug Product
Table 94. Sanofi-Aventis S.A. Recent Developments/Updates
Table 95. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 96. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 97. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product
Table 99. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 100. Oxynorm Corporation Information
Table 101. Oxynorm Description and Business Overview
Table 102. Oxynorm Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Oxynorm Oxycodone Drug Product
Table 104. Oxynorm Recent Developments/Updates
Table 105. OxyContin Corporation Information
Table 106. OxyContin Description and Business Overview
Table 107. OxyContin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. OxyContin Oxycodone Drug Product
Table 109. OxyContin Recent Developments/Updates
Table 110. Endone Corporation Information
Table 111. Endone Description and Business Overview
Table 112. Endone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Endone Oxycodone Drug Product
Table 114. Endone Recent Developments/Updates
Table 115. Proladone Corporation Information
Table 116. Proladone Description and Business Overview
Table 117. Proladone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Proladone Oxycodone Drug Product
Table 119. Proladone Recent Developments/Updates
Table 120. Targin Corporation Information
Table 121. Targin Description and Business Overview
Table 122. Targin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Targin Oxycodone Drug Product
Table 124. Targin Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Oxycodone Drug Distributors List
Table 128. Oxycodone Drug Customers List
Table 129. Oxycodone Drug Market Trends
Table 130. Oxycodone Drug Market Drivers
Table 131. Oxycodone Drug Market Challenges
Table 132. Oxycodone Drug Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oxycodone Drug
Figure 2. Global Oxycodone Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oxycodone Drug Market Share by Type in 2023 & 2030
Figure 4. Pain Management Product Picture
Figure 5. Anesthesia Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oxycodone Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Oxycodone Drug Market Share by Application in 2023 & 2030
Figure 9. Hospitals & Clinics
Figure 10. Ambulatory Surgical Centers (ASCs)
Figure 11. Global Oxycodone Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Oxycodone Drug Market Size (2019-2030) & (US$ Million)
Figure 13. Global Oxycodone Drug Sales (2019-2030) & (K Units)
Figure 14. Global Oxycodone Drug Average Price (USD/Unit) & (2019-2030)
Figure 15. Oxycodone Drug Report Years Considered
Figure 16. Oxycodone Drug Sales Share by Manufacturers in 2023
Figure 17. Global Oxycodone Drug Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Oxycodone Drug Players: Market Share by Revenue in 2023
Figure 19. Oxycodone Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Oxycodone Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Oxycodone Drug Sales Market Share by Country (2019-2030)
Figure 22. North America Oxycodone Drug Revenue Market Share by Country (2019-2030)
Figure 23. United States Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Oxycodone Drug Sales Market Share by Country (2019-2030)
Figure 26. Europe Oxycodone Drug Revenue Market Share by Country (2019-2030)
Figure 27. Germany Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Oxycodone Drug Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Oxycodone Drug Revenue Market Share by Region (2019-2030)
Figure 34. China Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Oxycodone Drug Sales Market Share by Country (2019-2030)
Figure 44. Latin America Oxycodone Drug Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Oxycodone Drug Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Oxycodone Drug Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Oxycodone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Oxycodone Drug by Type (2019-2030)
Figure 54. Global Revenue Market Share of Oxycodone Drug by Type (2019-2030)
Figure 55. Global Oxycodone Drug Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Oxycodone Drug by Application (2019-2030)
Figure 57. Global Revenue Market Share of Oxycodone Drug by Application (2019-2030)
Figure 58. Global Oxycodone Drug Price (USD/Unit) by Application (2019-2030)
Figure 59. Oxycodone Drug Value Chain
Figure 60. Oxycodone Drug Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
